EU AI Act Guide

EU AI Act for US companies

US companies should treat the EU AI Act as an operational exposure question, not only as a legal topic. The first step is to map where AI systems touch EU markets, EU users, EU customers or EU-operational outputs.

Run the diagnostic first

Operational information, not legal advice.

Company exposure map

EU AI Act for US Companies

01

Business context

02

EU customers, users or output

03

AI product or workflow use

04

Exposure path

Strategic answer

US companies should map EU exposure before they plan compliance work.

For a US company, the EU AI Act is not only a European legal topic. It becomes operationally relevant when AI systems touch EU users, EU customers, EU market access, EU-facing outputs or regulated workflows. The first useful step is to map where exposure exists before building policies, documentation or implementation plans.

Start with the EU AI Act Diagnostic, turn findings into an implementation plan, and see how the diagnostic works as a reference app on M13.

Exposure focus

Where US exposure usually starts

  • The company offers an AI product, workflow or service into the European market.
  • EU customers use or rely on AI outputs produced by the company.
  • The AI system supports business processes that affect EU users, workers, applicants or customers.
  • A vendor, partner or internal team deploys AI into an EU-facing operational context.

First action

What to organize first

  1. 01List the AI systems that touch EU users, customers or workflows.
  2. 02Separate product exposure from internal deployment exposure.
  3. 03Identify whether the company acts as provider, deployer or another operational actor.
  4. 04Run high-risk triage before assigning implementation budget.

This page provides operational information for AI governance readiness. It is not legal advice.